Metformin, one of the most widely used oral hypoglycemic agents in the world, plays an important role in treating type 2 diabetes for decades, and it has been recommended as a first-line drug in diabetes guidelines around the world because of the good efficacy and safety for monotherapy and combination therapy, evidence of health economic benefits, and definite clinical evidence in the prevention of cardiovascular complications.

Metformin has been clinically applied for more than 30 years in China. However, some clinicians and patients still have misunderstandings about the use of metformin, which makes some patients, that could formally benefit from metformin therapy miss treatment opportunities. Therefore, the Chinese Expert Consensus Statement on Metformin in Clinical Practice was jointly formed by endocrinologists and pharmaceutical experts with the aim of guiding clinicians and patients to correctly understand and rationally use Metformin (Supplementary file).

By using a question-and-answer format, this consensus addressed the clinical status and initial treatment opportunity, mechanism, drug dose and clinical efficacy, drug use in special diabetic populations, safety, effects on cardiovascular system, which included six modules and 17 main recommendations about combination medication of Metformin. Main recommendations are presented in Table [1](#T1){ref-type="table"}.

###### 

Main recommendations of metformin therapy.
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Recommendations were formulated using the Class of Recommendation (COR) and Level of Evidence (LOE) system by the American College of Cardiology and American Heart Association.^\[[@R1]\]^ This system provides a transparent mechanism to judge benefit relative to risk using a classification scheme (I, IIa, IIb, and III), supported by evidence quality and quantity using an LOE rating (A, B-Randomized, B-Non-randomized, C-Limited data, C-Expert opinion, all recommendations are listed with a COR and LOE rating.

**The Expert Group members:**

Yi-Ming Mu^1^, Li-Nong Ji^2^, Guang Ning^3^, Guang-Wei Li^4^, Zhong-Yan Shan^5^, Yan Li^6^, Zi-Lin Sun^7^, Yan-Bing Li^8^, Jia-Jun Zhao^9^, Wei-Qing Wang^2^, Da-Long Zhu^10^, Tian-Pei Hong^11^, Nan-Wei Tong^12^, Zhi-Guang Zhou^13^, Da-Jin Zou^14^, Chao Liu^15^, Qiang Li^16^, Li-Xin Guo^17^, Yong-De Peng^18^, Lu-Lu Chen^19^, Xin-Hua Xiao^20^, Xue-Feng Yu^21^, You-Min Wang^22^, Qiu-He Ji^23^, Qi-Fu Li^24^, Chun-Lin Li^25^, Quan-Min Li^26^, Li-Xin Shi^27^, Yi-Ming Li^28^, Yong-Quan Shi^29^, Suo-Di Zhai^30^, Zhi-Gang Zhao^31^, Wan-Hua Yang^32^, Li-Wei Ji^33^, Rong-Sheng Zhao^30^, Jiu-Hong Wu^34^

^1^Department of Endocrinology, People\'s Liberation Army General Hospital, Beijing 100853, China

^2^Department of Endocrinology, Peking University People\'s Hospital, Beijing 100044, China

^3^Department of Endocrinology and Metabolism, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200025, China

^4^Department of Endocrinology, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100037, China

^5^Department of Endocrinology, the First Hospital of China Medical University, Shenyang, Liaoning 110001, China

^6^Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China

^7^Department of Endocrinology, Zhongda Hospital Southeast University, Nanjing, Jiangsu 210009, China

^8^Department of Endocrinology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510000, China

^9^Department of Endocrinology, Shandong Provincial Hospital, Jinan, Shandong 250021, China

^10^Department of Endocrinology, Nanjing Drum Tower Hospital, Nanjing, Jiangsu 210008, China

^11^Department of Endocrinology, Peking University Third Hospital, Beijing 100191, China

^12^Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China

^13^Department of Endocrinology and Metabolism, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China

^14^Department of Endocrinology, Department of Endocrinology, Changhai Hospital, Shanghai 200433, China

^15^Department of Endocrinology, Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, Jiangsu 210028, China

^16^Department of Endocrinology, Shenzhen University General Hospital, Shenzhen, Guangdong 518055, China

^17^Department of Endocrinology, Beijing Hospital, Beijing 100730, China

^18^Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai 200080, China

^19^Department of Endocrinology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430022, China

^20^Department of Endocrinology, Peking Union Medical College Hospital, Beijing 100730, China

^21^Department of Endocrinology, Tongji Medical College, Huazhong University of Science &Technology, Wuhan, Hubei 430030, China

^22^Department of Endocrinology, the First Affiliated Hospital of Medical University of Anhui, Hefei, Anhui 230022, China

^23^Department of Endocrinology, Xijing Hospital, Xi'an, Shaanxi 710032, China

^24^Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 404000, China

^25^Department of Geriatric Endocrinology, People\'s Liberation Army General Hospital, Beijing 100853, China

^26^Department of Endocrinology, Rocket People\'s Liberation Army General Hospital, Beijing 100088, China

^27^Department of Endocrinology and Metabolism, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, China

^28^Department of Endocrinology, Shanghai Huashan Hospital, Shanghai 200040, China

^29^Department of Endocrinology, Shanghai Changzheng Hospital, Shanghai 200433, China

^30^Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China

^31^Department of Pharmacy, Beijing Tiantan Hospital, Beijing 100050, China

^32^Department of Pharmacy, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200025, China

^33^Department of Pharmacy, Beijing Hospital, Beijing 100730, China

^34^Department of Pharmacy, Special Medical Center of Strategic Support Forces, Beijing 100101, China.

Conflicts of Interest
=====================

None.

Supplementary Material
======================

###### Supplemental Digital Content

**How to cite this article:** Expert Group of Metformin in Clinical Practice. Chinese expert consensus statement on metformin in clinical practice. Chin Med J 2020;133:1445--1447. doi: 10.1097/CM9.0000000000000883
